US Patent Issued to Precision Biologics on Oct. 28 for "Colon and pancreas cancer peptidomimetics" (New York Inventor)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,560, issued on Oct. 28, was assigned to Precision Biologics Inc. (Bethesda, Md.).

"Colon and pancreas cancer peptidomimetics" was invented by Xue-Ping Wang (Port Washington, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a peptidomimetic of an NPC-1 epitope on the MUC5AC protein which is differentially expressed in pancreatic and colorectal cancer, and diagnostic and therapeutic usages. Further, antibodies that selectively bind the NPC-1 epitope peptidomimetics and may be used in diagnostic and therapeutic methods."

The patent was filed on June 24, 2021, under Application No. 17/356,605.

*For further information, incl...